ACR image Mertix, an international imaging contract organization (CRO) including expertise in imaging trial design , techniques and data extraction, organized a recent event titled “The Novel Medical imaging Approaches for Early Drug Development Methods, technical issues and case studies” which took place at the at the Boston Marriott Cambridge, in Cambridge Massachusetts on the 16th of September.Bruce Hillman, Chief scientific officer, M.D., FACR, of ACR Image Metrix, carried out a presentation titled, "Methodologic Considerations in Designing Pharmaceutical Trials Using Novel Imaging Methods."ACR Image Mertix is a leader in worldwide imaging trials. Industry experts from ACR Image Metrix offered great caliber research on ways and technical problems related to clinical trials. Mehdi Adineh , Ph.D., Scientific director of ACR Image Metrix imaging core laboratory, conducted a presentation named "Increasing the Effectiveness of Novel Imaging in Clinical Trials: The Role of the Imaging Core Laboratory,” while Greg Sorenson, a professor of radiology at Harvard Medical School, Massachusetts General Hospital ,M.D, had a presentation titled "Mechanistic Imaging in Cancer Trials: Lessons from Glioblastoma."
No comments:
Post a Comment